Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
Plos One
|
May 8, 2015
DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial
Julie E Ledgerwood, Abbie R Bellamy, Robert Belshe, et al.
Contemporary Clinical Trials
|
August 16, 2015
Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost
Julie E Ledgerwood, Zonghui Hu, Pamela Costner, et al.
Plos One
|
November 16, 2016
Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)
Michelle C Crank, Eleanor M P Wilson, Laura Novik, et al.
The Journal of Infectious Diseases
|
September 17, 2014
Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial
Uzma N Sarwar, Pamela Costner, Mary E Enama, et al.
The Journal of Infectious Diseases
|
March 15, 2011
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial
Julie E Ledgerwood, Theodore C Pierson, Sarah A Hubka, et al.
Vaccine
|
October 1, 2008
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
Julie E Martin, Mark K Louder, LaSonji A Holman, et al.
Clinical and Vaccine Immunology : CVI
|
September 22, 2006
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
Julie E Martin, Nancy J Sullivan, Mary E Enama, et al.
Plos One
|
September 19, 2019
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial
Cristina Carter, Katherine V Houser, Galina V Yamshchikov, et al.
Plos One
|
November 3, 2018
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial
Katherine V Houser, Galina V Yamshchikov, Abbie R Bellamy, et al.
Plos One
|
April 18, 2015
Phase 1 study of pandemic H1 DNA vaccine in healthy adults
Michelle C Crank, Ingelise J Gordon, Galina V Yamshchikov, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
Plos One
|
May 8, 2015
DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial
Julie E Ledgerwood, Abbie R Bellamy, Robert Belshe, et al.
Contemporary Clinical Trials
|
August 16, 2015
Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost
Julie E Ledgerwood, Zonghui Hu, Pamela Costner, et al.
Plos One
|
November 16, 2016
Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)
Michelle C Crank, Eleanor M P Wilson, Laura Novik, et al.
The Journal of Infectious Diseases
|
September 17, 2014
Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial
Uzma N Sarwar, Pamela Costner, Mary E Enama, et al.
The Journal of Infectious Diseases
|
March 15, 2011
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial
Julie E Ledgerwood, Theodore C Pierson, Sarah A Hubka, et al.
Vaccine
|
October 1, 2008
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
Julie E Martin, Mark K Louder, LaSonji A Holman, et al.
Clinical and Vaccine Immunology : CVI
|
September 22, 2006
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
Julie E Martin, Nancy J Sullivan, Mary E Enama, et al.
Plos One
|
September 19, 2019
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial
Cristina Carter, Katherine V Houser, Galina V Yamshchikov, et al.
Plos One
|
November 3, 2018
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial
Katherine V Houser, Galina V Yamshchikov, Abbie R Bellamy, et al.
Plos One
|
April 18, 2015
Phase 1 study of pandemic H1 DNA vaccine in healthy adults
Michelle C Crank, Ingelise J Gordon, Galina V Yamshchikov, et al.
Page
of 4